SMA News Today latest article: "SMA Europe’s inaugural gathering to discuss medical emergencies"
We're excited to announce that SMA News Today has featured our 1st International Clinical Care Symposium on SMA, as part of their latest publication!
SMA Newsroom
TreatmentsMar 28, 2025
Community update from Scholar Rock
Scholar Rock announced that the FDA has granted priority review for the Biologics License Application for apitegromab, an investigational muscle-targeted treatment developed to improve motor function for people living with SMA who are receiving an SMN-targeted treatment.
TreatmentsMar 21, 2025
Community update from Roche: Final five-year data from the pivotal SUNFISH (NCT02908685) study
Roche shared updates on the final results of the now-concluded SUNFISH study, which assessed the efficacy and safety of risdiplam in people living with SMA aged 2-25 years.
TreatmentsMar 21, 2025
Community update from Novartis: Phase III STEER and Phase IIIb STRENGTH studies
Novartis shared updates on the results from Phase III STEER and Phase IIIb STRENGTH studies, evaluating intrathecal onasemnogene abeparvovec (OAV101 IT) in people living with SMA aged two to <18 years.